{"id":"W4317934829","doi":"10.51731/cjht.2023.551","title":"Trastuzumab Deruxtecan (Enhertu)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Trastuzumab; Reimbursement; Medicine; Regimen; Adjuvant; Oncology; Breast cancer; Internal medicine; Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Cancer; Health care","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00128652,0.0001256626,0.0004479542,0.001564256,0.0002285508,0.00003117623,0.000394894,0.0001743768,0.0001167992],"category_scores_gemma":[0.001358771,0.0001056879,0.00009811665,0.001295899,0.0003026882,0.00006405709,0.00002663774,0.0008709455,0.0001098128],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001203325,"about_ca_system_score_gemma":0.01088883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005445633,"about_ca_topic_score_gemma":0.006521521,"domain_scores_codex":[0.9979847,0.00005862126,0.0005687961,0.0001560058,0.0003635105,0.0008683832],"domain_scores_gemma":[0.998843,0.00007875373,0.0001969863,0.0003475361,0.0002411528,0.0002925415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001695462,0.00001000298,0.007698179,0.0002100492,0.00003902148,0.001107619,0.0003259935,0.000006602539,0.00008385337,0.0002944659,0.0763762,0.9138311],"study_design_scores_gemma":[0.000910864,0.001617331,0.04078701,0.000782995,0.0000159048,0.001344925,0.007961091,0.00003621994,0.001237449,0.004319933,0.9408174,0.0001689302],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.4534305,0.07818354,0.0002885124,0.4622791,0.001370053,0.0009390177,0.00005155147,0.0008960994,0.002561602],"genre_scores_gemma":[0.9965783,0.001651867,0.0005112512,0.0007065907,0.0000343797,0.00001078974,0.000003227698,0.00003092611,0.0004726464],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9136621,"threshold_uncertainty_score":0.9947185,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1028653130584693,"score_gpt":0.398326580389078,"score_spread":0.2954612673306086,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}